HypeCheck(in) – Week 1 with weight loss tools

GroanEditors note: This post is a day late due to the snow.

I have to say, I had some pretty lofty expectations about the tools I had selected when starting this program. I chose them because the tech press singled them out as being outstanding in their respective categories. Turns out my real-world experience was a mixed bag. To recap, last week I discussed my plan to finally try to lose weight and selected the Microsoft Band, The Withings Smart Body Analyzer, and The MyFitnessPal Pro app to help gather data and monitor my progress along the way. Before I give my impressions of the benefits of these devices, let’s get the accountabilities out of the way.

Week 1 Progress Report
Beginning weight: 223 lbs
After week 1: 220.7 lbs
Net Result: -2.3 lbs

Beginning BMI: 30%
After week 1: 30%
Net Result: Even

Beginning Fat Mass: 29.8%
After week 1: 30.1%
Net Result: +0.3%

Overall I didn’t have the greatest week eating-wise, but I did manage to stick to my exercise plan. (For those who are wondering, I’m using the weight/cardio combo plan from this book). Using the devices added a certain amount of help and difficulty to the process, so I’m going to make some adjustments. I’ll go device by device. Read More…

Friday Follow Ups

Smoking Will Kill You

How the camera doomed Google Glass – Looking like a tool didn’t help either.

Microsoft’s Holo Lens debuts – Could Redmond be getting it’s swagger back?

Temporary tattoo that tests blood sugar – An honest to goodness product to help diabetics. Unlike some other products…

New Leatherman tool bracelet – WANT!

A typeface designed by algorithms – Surprise! It’s Comic Sans. (Kidding!)

YTT Podcast Ep 02: Automated Sincerity

Special guest Jonathan Richman joins the show to discuss the state of market research in pharma, the lack of quality tools for the job, why pharma websites are terrible, the agency/client fight over social media and communications, where content production is heading, and to plug his new company. Unbeknownst to me, the gain on my mic was a tad low, so my audio is a bit murky. It’s episode 2, call it part of the learning curve.

Get the show notes and download links here.

The pharma implications of the FDA’s policy on low risk devices


On January 19th, the FDA released draft guidance about wearables dated January 20th, proving not only do they have access to a time machine, but they are totally willing to rub our noses in it. The document, which you can download here, relates to the FDA’s policy on what it deems as “low risk devices,” i.e., wearables.

Low risk devices, by the FDA’s definition, are those that, “involve claims about sustaining or offering general improvement to conditions and functions associated with a general state of health that do not make any reference to diseases or conditions.” And, more specifically, a general wellness device has,

1)  intended uses to promote, track, and/or encourage choice(s), which, as part of a healthy lifestyle, may help to reduce the risk of certain chronic diseases or conditions; and,

2)  intended uses to promote, track, and/or encourage choice(s) which, as part of a healthy lifestyle, may help living well with certain chronic diseases or conditions.

Read More…